Navigation Links
February is Designated as 'National Care About Your Indoor Air' Month
Date:2/7/2008

>

purifier in the rooms where they spend the most time, such as the

bedroom and the living area (family room, living room, den, or home

office). Portable air purifiers can help circulate the air in a room,

usually several times per hour -- helping to reduce stuffy, stale air.

"The Healthy House Institute (HHI) strives to be the most comprehensive online educational resource available for creating healthier homes," said Allen Rathey, president of HHI. "We support these efforts to bring broader consumer awareness to the issues surrounding indoor air quality and its potential impact on consumer health and safety."

Did You Know?

-- The EPA ranks poor indoor air quality among the top five environmental

risks to public health.

-- On average, adults take 900 breaths an hour -- or more than 21,600

breaths a day.

-- Even in the cleanest of homes, indoor air can be dirty. Indoor air

pollution can be triggered by factors all around us, including dust,

pet dander, mold/mildew, pollen and tobacco smoke. Microscopic

particulates can be inhaled deep into the lungs, posing potential

health risks for even healthy adults and children.

-- According to the EPA, poor indoor air quality can cause lack of

concentration in school children.

-- According to the American Lung Association, asthma (which can be

triggered by either indoor or outdoor air pollution) accounts for an

estimated three million lost workdays for adults and 10.1 million lost

school days for children each year. Asthma costs our nation $16.1

billion in health care costs annually.

-- Approximately 160 million Americans are breathing unhealthy air --

children and seniors are the age groups most at risk.

About Kaz, Inc.

For more information on Honeywell air purifiers and how to help control indoor air pollution, visi
'/>"/>

SOURCE Kaz, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Emageon Inc. to Host Fourth Quarter 2007 Financial Results Conference Call February 21, 2008
2. Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13, 2008
3. Galaxy Nutritional Foods Announces Third Quarter FY2008 Earnings Conference Call for Friday, February 8, 2008
4. The Female Health Company Schedules First Quarter Conference Call for February 13, 2008
5. Jazz Pharmaceuticals, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 13, 2008
6. BioMarin to Host Fourth Quarter and Full Year 2007 Financial Results Conference Call and Webcast on Tuesday, February 26 at 5:00 p.m. ET (23:00 CET)
7. Favrille to Host Conference Call and Live Webcast to Discuss Fourth Quarter and Year End 2007 Financial Results on February 19, 2008
8. Student Health Advocates to Rally at the State Capitol on February 5
9. East Meets West at Cabo San Lucas New Saltwater Spa, Opening February
10. Providence Service Corporation to Present at the 2008 UBS Global Healthcare Services Conference on February 11
11. The UV Foundation Announces February is Vitamin D Deficiency Month
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6When palm trees gave way to spruce trees 8890 1When palm trees gave way to spruce trees 8890 2House Subcommittee Markup Leaves Global Fund to Fight AIDS TB and Malaria in Crisis 49310 1House Subcommittee Markup Leaves Global Fund to Fight AIDS TB and Malaria in Crisis 49310 2Mayo Clinic Plans Facility at Mall of America 49306 1Mayo Clinic Plans Facility at Mall of America 49306 2Mayo Clinic Plans Facility at Mall of America 49306 3